Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John’s Wort?

Dresser, 2002, A basic conceptual and practical overview of interactions with highly prescribed drugs, Can. J. Clin. Pharmacol., 9, 191 Lin, 1998, Inhibition and induction of cytochrome P450 and the clinical implications, Clin. Pharmacokinet., 35, 361, 10.2165/00003088-199835050-00003 Goldberg, 1996, Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population, Am. J. Emerg. Med., 14, 447, 10.1016/S0735-6757(96)90147-3 Shou, 2005, Prediction of pharmacokinetics and drug–drug interactions from in vitro metabolism data, Curr. Opin. Drug Discov. Dev., 8, 66 Watkins, 1992, Drug metabolism by cytochromes P450 in liver and small bowel, Gastrointest. Pharmacol., 21, 511 Paine, 2006, The human intestinal cytochrome P450 pie, Drug Metab. Dispos., 34, 880, 10.1124/dmd.105.008672 De Boer, 2015, Adverse food-drug interactions, Regul. Toxicol. Pharmacol., 73, 859, 10.1016/j.yrtph.2015.10.009 Genser, 2008, Food and drug interaction: consequences for the nutrition/health status, Ann. Nutr. Metab., 52, 29, 10.1159/000115345 Won, 2012, Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport, Pharmacol. Ther., 136, 186, 10.1016/j.pharmthera.2012.08.001 Singh, 2004, Effects of food on the clinical pharmacokinetics of anticancer agents, Clin. Pharmacokinet., 43, 1127, 10.2165/00003088-200443150-00005 Lin, 2010, Impact of food and antiacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis, Int. J. Tuberc. Lung Dis., 14, 806 Jauregui-Garrido, 2012, Interactions between antihypertensive drugs and food, Nutr. Hosp., 27, 1866 Darbar, 1997, Dietary salt increases first-pass elimination of oral quinidine, Clin. Pharmacol. Ther., 61, 292, 10.1016/S0009-9236(97)90161-2 Talavera Pons, 2016, Managing drug–drug interactions with new direct-acting antiviral agents in chronic hepatitis C, Br. J. Clin. Pharmacol. Ohnishi, 2004, Interactions between medicines and functional foods or dietary supplements, Keio J. Med., 53, 137, 10.2302/kjm.53.137 Heuberger, 2012, Polypharmacy and food-drug interactions among older persons: a review, J. Nutr. Gerontol. Geriatr., 31, 325, 10.1080/21551197.2012.729902 McCabe, 2004, Prevention of food-drug interactions with special emphasis on older adults, Curr. Opin. Clin. Nutr. Metab. Care, 7, 21, 10.1097/00075197-200401000-00005 Weaver, 2001, Assessment of drug–drug interactions: concept and approaches, Xenobiotica, 31, 499, 10.1080/00498250110060950 Schmidt, 2002, Food-drug interactions, Drugs, 62, 1481, 10.2165/00003495-200262100-00005 Chan, 2002, Drug-nutrient interaction in clinical nutrition, Curr. Opin. Clin. Nutr. Metab. Care, 5, 327, 10.1097/00075197-200205000-00014 Eagle, 2012, Toxicological effects of red wine, orange juice, and other dietary SULT1A inhibitors via excess catecholamines, Food Chem. Toxicol., 50, 2243, 10.1016/j.fct.2012.03.004 Thummel, 1997, Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction, Adv. Drug Deliv. Rev., 27, 99, 10.1016/S0169-409X(97)00039-2 Hall, 1999, Molecular and physical mechanisms of first-pass extraction, Drug Metab. Dispos., 27, 161 Krishna, 1994, Extrahepatic metabolism of drugs in humans, Clin. Pharmacokinet., 26, 144, 10.2165/00003088-199426020-00007 Mouly, 2003, P-glycoprotein increases from proximal to distal regions of human small intestine, Pharm. Res., 20, 1595, 10.1023/A:1026183200740 Thiebaut, 1987, Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues, Proc. Natl. Acad. Sci. U. S. A., 84, 7735, 10.1073/pnas.84.21.7735 Zhang, 2001, The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein, Clin. Pharmacokinet., 40, 159, 10.2165/00003088-200140030-00002 Watkins, 1997, Barrier function of CYP3A4 and P-glycoprotein in the small bowel, Adv. Drug Deliv. Rev., 27, 161, 10.1016/S0169-409X(97)00041-0 Wacher, 1995, Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy, Mol. Carcinog., 13, 129, 10.1002/mc.2940130302 Butterweck, 2004, Pharmacokinetic herb-drug interactions: are preventive screenings necessary and appropriate, Planta Med., 70, 784, 10.1055/s-2004-827223 Aszalos, 2008, Role of ATP-binding cassette (ABC) transporters in interactions between natural products and drugs, Curr. Drug Metab., 9, 1010, 10.2174/138920008786927776 Rodriguez-Fragoso, 2011, Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters, J. Food Sci., 76, R112, 10.1111/j.1750-3841.2011.02155.x Shi, 2015, The interaction between natural products and OATP1B1, Yao Xue Xue Bao, 50, 848 Gruenwald, 2009, Novel botanical ingredients for beverages, Clin. Dermatol., 27, 210, 10.1016/j.clindermatol.2008.11.003 Bailey, 1998, Grapefruit juice-drug interactions, Br. J. Clin. Pharmacol., 46, 101, 10.1046/j.1365-2125.1998.00764.x Kane, 2000, Drug-Grapefruit juice interactions, Mayo Clin. Proc., 75, 933, 10.4065/75.9.933 Lohezic-Le Devehat, 2002, Jus de pamplemousse et medicaments: une association à surveiller?, Thérapie, 57, 432 Bailey, 2013, Grapefruit-medication interactions: forbidden fruit or avoidable consequences, CMAJ, 185, 309, 10.1503/cmaj.120951 Dresser, 2003, The effects of fruit juices on drug disposition: a new model for drug interactions, Eur. J. Clin. Invest., 33, 10, 10.1046/j.1365-2362.33.s2.2.x Hanley, 2011, The effect of grapefruit juice on drug disposition, Expert Opin. Drug Metab. Toxicol., 7, 267, 10.1517/17425255.2011.553189 Seden, 2010, Grapefruit-drug interactions, Drugs, 70, 2373, 10.2165/11585250-000000000-00000 Nieminen, 2010, Grapefruit juice enhances the exposure to oral oxycodone, Basic Clin. Pharmacol. Toxicol., 107, 782, 10.1111/j.1742-7843.2010.00582.x Liukas, 2011, Inhibition of cytochrome P450 3A by clarithromycin uniformly affects the pharmacokinetics and pharmacodynamics of oxycodone in young and elderly volunteers, J. Clin. Psychopharmacol., 31, 302, 10.1097/JCP.0b013e3182189892 Jauregui-Garrido, 2012, Interactions between antiarythmic drugs and food, Nutr. Hosp., 27, 1399 Paine, 1997, Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism, J. Pharmacol. Exp. Ther., 283, 1552 Greenblatt, 2003, Time course of recovery of cytochrome P450 3A function after single dose of grapefruit juice, Clin. Pharmacol. Ther., 74, 121, 10.1016/S0009-9236(03)00118-8 Lilja, 2000, Duration of effect of grapefruit juice on the pharmacokinetics of the CYP3A4 substrate simvastatin, Clin. Pharmacol. Ther., 68, 384, 10.1067/mcp.2000.110216 Dolton, 2012, Fruit juices as perpetrators of drug interactions: the role of organic anion-transporting polypeptides, Clin. Pharmacol. Ther., 92, 622, 10.1038/clpt.2012.159 Srinivas, 2013, Cranberry juice ingestion and clinical drug–drug interaction potentials; review of case studies and perspectives, J. Pharm. Pharm. Sci., 16, 289, 10.18433/J3NG6Z Foods, 2003, genetics, and drug interactions, J. Clin. Psychopharmacol., 23, 221, 10.1097/01.jcp.0000084022.22282.4a Borrelli, 2007, Garlic (Allium savitum L.): adverse effects and drug interactions in humans, Mol. Nutr. Food Res., 51, 1386, 10.1002/mnfr.200700072 Pasko, 2016, Interactions between medications employed in treating benign prostatic hyperplasia and food—a short review, Biomed. Pharmacother., 83, 1141, 10.1016/j.biopha.2016.08.021 Unger, 2013, Pharmacokinetic drug interactions involving Ginkgo biloba, Drug Metab. Rev., 56, 353, 10.3109/03602532.2013.815200 Abebe, 2002, Herbal medication: potential for adverse interactions with analgesics drugs, J. Clin. Pharm. Ther., 27, 391, 10.1046/j.1365-2710.2002.00444.x Boullata, 2005, Natural health product interactions with medication, Nutr. Clin. Pract., 20, 33, 10.1177/011542650502000133 Rogovik, 2010, Safety considerations and potential interactions of vitamins: should vitamins be considered drugs, Ann. Pharmacother., 44, 311, 10.1345/aph.1M238 Hussain, 2011, Patient counseling about herbal-drug interactions, Hussain Afr. J. Tradit. Complement. Altern. Med., 8, 152 Nutescu, 2011, Drug and dietary interactions of warfarin and novel oral anticoagulants: an update, J. Thromb. Thrombolysis, 31, 326, 10.1007/s11239-011-0561-1 Vieira MdL.T. Huang, 2012, Botanical-drug interactions: a scientific perspective, Planta Med., 78, 1400, 10.1055/s-0032-1315145 Fugh-Berman, 2000, Herb-drug interactions, Lancet, 355, 134, 10.1016/S0140-6736(99)06457-0 Nowack, 2008, Review article: cytochrome P450 enzyme, and transport protein mediated herb-drug interactions in renal transplant patients: grapefruit juice, St John’s Wort −and beyond!, Nephrology, 13, 337, 10.1111/j.1440-1797.2008.00940.x Nowack, 2009, Effects of dietary factors on drug transport and metabolism: the impact on dosage guidelines in transplant patients, Clin. Pharmacol. Ther., 85, 439, 10.1038/clpt.2008.303 Nieminen, 2010, St John’s wort greatly reduces the concentrations of oral oxycodone, Eur. J. Pain, 14, 854, 10.1016/j.ejpain.2009.12.007 Taneja, 2016, Dietary isoflavones as modulators of drug metabolizing enzymes and transporters: effect on prescription medicines, Crit. Rev. Food Sci. Nutr., 56, S95, 10.1080/10408398.2015.1045968 Peng, 2003, Effect of daidzein on CYP1A2 activity and pharmacokinetics of theophylline in healthy volunteers, Eur. J. Clin. Pharmacol., 59, 237, 10.1007/s00228-003-0596-0 Nakajima, 2006, Isoflavones inhibit nicotine C-oxidation catalyzed by human CYP2A6, J. Clin. Pharmacol., 46, 337, 10.1177/0091270005285199 Karadima, 2016, Drug-micronutrient interactions: food for thought and thought for action, EPMA J., 7, 1, 10.1186/s13167-016-0059-1 Mirtallo, 2004, Complications associated with drug and nutrient interactions, J. Infus. Nurs., 27, 19, 10.1097/00129804-200401000-00003 Camilleri, 2016, Drug-resin drug interactions in patients with delayed gastric emptying: what is the optimal time window for drug administration, Neurogastroenterol. Motil., 28, 1268, 10.1111/nmo.12823 Gonzales Canga, 2010, Dietary fibers and its interaction with drugs, Nutr. Hosp., 25, 535 Holbrook, 2005, Systematic overview of warfarin and its drug and food interactions, Arch. Intern. Med., 165, 1095, 10.1001/archinte.165.10.1095 Leite, 2016, Review on mechanisms and interactions in concomitant use of herbs and warfarin therapy, Biomed. Pharmacother., 83, 14, 10.1016/j.biopha.2016.06.012 Walenga, 2010, Drug and diatery interactions of the new and emerging oral anticoagulants, Int. J. Clin. Pract., 64, 956, 10.1111/j.1742-1241.2009.02286.x Voukalis, 2016, Drug-drug interactions of non-vitamin K oral anticoagulants, Expert Opin. Drug Metab., 18 Tilson, 2016, Recommendations for selecting drug–drug interactions for clinical decision support, Am. J. Health. Syst. Pharm., 73, 576, 10.2146/ajhp150565